Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Kaiser

Showing results (121-130 of 160) with videos related to

Pageof 16
Sort By:
European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society|June 1, 2023
Epidemiology and injury morphology of traumatic hip dislocations in children and adolescents in Germany: a multi-centre studyMirjam Evi Braun, Oliver Loose, Peter Schmittenbecher, et al.
Insights Into Imaging|February 16, 2024
Curation of myeloma observational study MALIMAR using XNAT: solving the challenges posed by real-world dataSimon J Doran, Theo Barfoot, Linda Wedlake, et al.
Journal of Cancer Policy|January 9, 2026
Accelerating cancer treatment optimisation: A multistakeholder roadmap from the Cancer Medicines ForumDenis Lacombe, Fábio Cardoso Borges, Ana E Amariutei, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 24, 2006
Synthesis, crystal structures, linear and nonlinear optical properties, and theoretical studies of (p-R-phenyl)-, (p-R-phenylethynyl)-, and (E)-[2-(p-R-phenyl)ethenyl]dimesitylboranes and related compoundsZheng Yuan, Christopher D Entwistle, Jonathan C Collings, et al.
Molecular Phylogenetics and Evolution|June 26, 2024
Museomics help resolving the phylogeny of snowfinches (Aves, Passeridae, Montifringilla and allies)Safiqul Islam, Claire Peart, Christian Kehlmaier, et al.
Clinical Pharmacology and Therapeutics|February 11, 2026
Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World DataFrancesco Pignatti, Tarec Christoffer El-Galaly, Martin Kaiser, et al.
Insights Into Imaging|July 28, 2022
Implementation of Whole-Body MRI (MY-RADS) within the OPTIMUM/MUKnine multi-centre clinical trial for patients with myelomaMihaela Rata, Matthew Blackledge, Erica Scurr, et al.
Blood Advances|April 23, 2021
Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myelomaChristie P M Verkleij, Marloes E C Broekmans, Mark van Duin, et al.
BMJ Open|June 2, 2022
<i>F</i>railty-adjusted therapy <i>i</i>n <i>T</i>ransplant <i>N</i>on-<i>E</i>ligible patient<i>s</i> with newly diagno<i>s</i>ed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trialAmy Beth Coulson, Kara-Louise Royle, Charlotte Pawlyn, et al.
Haematologica|July 15, 2021
2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. HydePellegrino Musto, Monika Engelhardt, Jo Caers, et al.
Pageof 16

Showing results (121-130 of 160) with videos related to

Sort By:
Pageof 16
European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society|June 1, 2023
Epidemiology and injury morphology of traumatic hip dislocations in children and adolescents in Germany: a multi-centre studyMirjam Evi Braun, Oliver Loose, Peter Schmittenbecher, et al.
Insights Into Imaging|February 16, 2024
Curation of myeloma observational study MALIMAR using XNAT: solving the challenges posed by real-world dataSimon J Doran, Theo Barfoot, Linda Wedlake, et al.
Journal of Cancer Policy|January 9, 2026
Accelerating cancer treatment optimisation: A multistakeholder roadmap from the Cancer Medicines ForumDenis Lacombe, Fábio Cardoso Borges, Ana E Amariutei, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 24, 2006
Synthesis, crystal structures, linear and nonlinear optical properties, and theoretical studies of (p-R-phenyl)-, (p-R-phenylethynyl)-, and (E)-[2-(p-R-phenyl)ethenyl]dimesitylboranes and related compoundsZheng Yuan, Christopher D Entwistle, Jonathan C Collings, et al.
Molecular Phylogenetics and Evolution|June 26, 2024
Museomics help resolving the phylogeny of snowfinches (Aves, Passeridae, Montifringilla and allies)Safiqul Islam, Claire Peart, Christian Kehlmaier, et al.
Clinical Pharmacology and Therapeutics|February 11, 2026
Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World DataFrancesco Pignatti, Tarec Christoffer El-Galaly, Martin Kaiser, et al.
Insights Into Imaging|July 28, 2022
Implementation of Whole-Body MRI (MY-RADS) within the OPTIMUM/MUKnine multi-centre clinical trial for patients with myelomaMihaela Rata, Matthew Blackledge, Erica Scurr, et al.
Blood Advances|April 23, 2021
Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myelomaChristie P M Verkleij, Marloes E C Broekmans, Mark van Duin, et al.
BMJ Open|June 2, 2022
<i>F</i>railty-adjusted therapy <i>i</i>n <i>T</i>ransplant <i>N</i>on-<i>E</i>ligible patient<i>s</i> with newly diagno<i>s</i>ed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trialAmy Beth Coulson, Kara-Louise Royle, Charlotte Pawlyn, et al.
Haematologica|July 15, 2021
2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. HydePellegrino Musto, Monika Engelhardt, Jo Caers, et al.
Pageof 16